Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants. | Biochem Biophys Res Commun | 2022 | 36041326 | PubTator, text mining | PubMed |
| Human Claudin-Derived Peptides Block the Membrane Fusion Process of Zika Virus and Are Broad Flavivirus Inhibitors. | Microbiol Spectr | 2022 | 36040168 | PubTator, text mining | PubMed |
| Missense mutations in spike protein of SARS-CoV-2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor. | Immun Inflamm Dis | 2022 | 36039645 | PubTator, text mining | PubMed |
| Antibody-mediated immunity to SARS-CoV-2 spike. | Adv Immunol | 2022 | 36038194 | PubTator, text mining | PubMed |
| The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals. | Front Vet Sci | 2022 | 36032286 | PubTator, text mining | PubMed |
| Diagnostic Performance of Three ELISAs for Detection of Antibodies against SARS-CoV-2 in Human Samples. | ScientificWorldJournal | 2022 | 36017468 | PubTator, text mining | PubMed |
| Dengue virus NS4B protein as a target for developing antivirals. | Front Cell Infect Microbiol | 2022 | 36017362 | PubTator, text mining | PubMed |
| PEDV: Insights and Advances into Types, Function, Structure, and Receptor Recognition. | Viruses | 2022 | 36016366 | PubTator, text mining | PubMed |
| Antibody-Dependent Enhancement: ″Evil″ Antibodies Favorable for Viral Infections. | Viruses | 2022 | 36016361 | PubTator, text mining | PubMed |
| CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection. | Viruses | 2022 | 36016357 | PubTator, text mining | PubMed |
| A Deacetylase CqSIRT1 Promotes WSSV Infection by Binding to Viral Envelope Proteins in Cherax quadricarinatus. | Viruses | 2022 | 36016356 | PubTator, text mining | PubMed |
| The Viral Origin of Human Breast Cancer: From the Mouse Mammary Tumor Virus (MMTV) to the Human Betaretrovirus (HBRV). | Viruses | 2022 | 36016325 | PubTator, text mining | PubMed |
| Histopathological Features of SARS-CoV-2 in Extrapulmonary Organ Infection: A Systematic Review of Literature. | Pathogens | 2022 | 36014988 | PubTator, text mining | PubMed |
| Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants. | Life (Basel) | 2022 | 36013424 | PubTator, text mining | PubMed |
| The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics. | Biomedicines | 2022 | 36009504 | PubTator, text mining | PubMed |
| The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection. | J Virol | 2022 | 36000850 | PubTator, text mining | PubMed |
| In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies. | Adv Appl Bioinform Chem | 2022 | 35996620 | PubTator, text mining | PubMed |
| Structural and Mechanistic Evidence for Calcium Interacting Sites in the HIV Transmembrane Protein gp41 Involved in Membrane Fusion. | Biochemistry | 2022 | 35994087 | PubTator, text mining | PubMed |
| Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic Games. | Front Microbiol | 2022 | 35992703 | PubTator, text mining | PubMed |
| Alphaherpesvirus glycoprotein E: A review of its interactions with other proteins of the virus and its application in vaccinology. | Front Microbiol | 2022 | 35992696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=44